[1]蒋云霞,罗伟生.荔枝核治疗肝脏疾病研究进展[J].西部中医药,2021,34(05):144-147.[doi:10.12174/j.issn.2096-9600.2021.05.37]
　JIANG Yunxia,LUO Weisheng.Research Progress of Litchi Seed in the Treatment of Hepatic Diseases[J].Western Journal of Traditional Chinese Medicine,2021,34(05):144-147.[doi:10.12174/j.issn.2096-9600.2021.05.37]
点击复制

荔枝核治疗肝脏疾病研究进展
分享到：

《西部中医药》[ISSN:2096-9600/CN:62-1204/R]

卷:
34
期数:
2021年05期
页码:
144-147
栏目:
研究进展
出版日期:
2021-05-15

文章信息/Info

Title:
Research Progress of Litchi Seed in the Treatment of Hepatic Diseases
作者:
蒋云霞, 罗伟生
广西中医药大学，广西 南宁 530000
Author(s):
JIANG Yunxia, LUO Weisheng
Guangxi University of Chinese Medicine, Nanning 530000, China
关键词:
抗乙肝病毒; 抗肝纤维化; 脂肪肝; 抑制肝癌; 荔枝核
Keywords:
anti-HBV; anti-fibrosis; fatty liver; inhibiting liver cancer; litchi seed
分类号:
R575
DOI:
10.12174/j.issn.2096-9600.2021.05.37
摘要:
综述荔枝核在抗乙肝病毒、抗肝纤维化及保护肝细胞、降血脂减轻脂肪肝、抑制肝癌及增强免疫等4个方面治疗肝脏疾病的相关研究进展，指出目前实验研究较多停留在荔枝核的粗提取物方面，缺乏具体、准确的生物药剂学与药物动力学等方面的研究，且荔枝核在治疗肝脏疾病方面完整、准确的分子机制及其信号传导通路尚无法明确，今后需进一步深入研究。
Abstract:
Research progress of litichi seed in the treatment of hepatic diseases was reviewed from four aspects: anti-HBV, anti-fibrosis and protecting liver cells, reducing blood lipid and relieving fatty liver, inhibiting liver cancer and enhancing the immunity, etc, it is pointed out that most of the experimental studies only stay on the crude extract of litchi seed, and lack of specific and accurate research on biopharmaceutics and pharmacokinetics, the complete and accurate molecular mechanism and signal transduction pathway of litchi seed in the treatment of hepatic disease are still unclear, and the future experimental research needs to be further studied.

备注/Memo

备注/Memo:
蒋云霞（1995—），女，在读硕士研究生。研究方向：脾胃病的中西医结合防治。国家自然科学基金（81660779）；广西创新驱动发展专项公开择优立项项目（2017AA21041）；2018年广西一流学科建设项目重点课题（2018XK035）。
更新日期/Last Update: 2021-05-15